Last reviewed · How we verify
Tomiron (cefteram pivoxil)
Tomiron (generic name: cefteram pivoxil) is a drug. It is currently in unknown development.
Tomiron works by stopping bacteria from building their cell walls, ultimately leading to their death.
Tomiron, also known as Cefteram, is a third-generation cephalosporin antibiotic. It is a small molecule modality.
At a glance
| Generic name | cefteram pivoxil |
|---|---|
| Therapeutic area | Infectious Disease |
| Phase | unknown |
Mechanism of action
Imagine bacteria as tiny factories that build their own walls to protect themselves. Tomiron blocks the machines that make these walls, causing the bacteria to die. This helps to treat infections caused by these bacteria.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tomiron CI brief — competitive landscape report
- Tomiron updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Tomiron
What is Tomiron?
How does Tomiron work?
What is the generic name of Tomiron?
What development phase is Tomiron in?
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Infectious Disease
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing